SPIRIT 2025 statement: updated guideline for protocols of randomised trials
An‐Wen Chan(World Health Organization), Asbjørn Hróbjartsson(University of Southern Denmark), Martin Offringa(Hospital for Sick Children), Lehana Thabane(Impact), Robert Golub(American Medical Association), Brennan C Kahan(MRC Clinical Trials Unit at UCL), Dawn P. Richards(Robarts Clinical Trials), Michael Berkwits(Centers for Disease Control and Prevention), R. Taylor(University of Oxford), Nita Bhandari, Sophie Staniszewska(University of Warwick), Sally Hopewell(University of Oxford), Philippe Ravaud(Inserm), Jesse A. Berlin(Janssen (Belgium)), Elizabeth Loder(Brigham and Women's Hospital), Runcie C.W. Chidebe(University of Miami), Kenneth F. Schulz(University of North Carolina at Chapel Hill), R. Tunn(Oxford BioMedica (United Kingdom)), Ian R. White(MRC Clinical Trials Unit at UCL), Gary S. Collins(NIHR Birmingham Biomedical Research Centre), Isabelle Boutron(Inserm), Dean Fergusson(Ottawa Hospital), Steff Lewis(University of Edinburgh), David Moher(University of Ottawa), Sarah E Lamb(University of Exeter), John P. A. Ioannidis(Innovative Research (United States)), Sunita Vohra(University of Alberta), Nancy J. Butcher(University of Toronto), David L. Schriger(University of California, Los Angeles), Nandi Siegfried(South African Medical Research Council), Marion Campbell(Hairmyres Hospital), Frank W. Rockhold(Amyloidosis Foundation), Tammy Hoffmann(Bond University), Rachel L Knowles(Great Ormond Street Hospital), David Torgerson(University of York), Diana Elbourne(London School of Hygiene & Tropical Medicine), Rakesh Aggarwal(Sanjay Gandhi Post Graduate Institute of Medical Sciences)
Cited by 79